These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3940679)

  • 1. Patterns of dyslipoproteinemia in selected North American populations. The Lipid Research Clinics Program Prevalence Study.
    LaRosa JC; Chambless LE; Criqui MH; Frantz ID; Glueck CJ; Heiss G; Morrison JA
    Circulation; 1986 Jan; 73(1 Pt 2):I12-29. PubMed ID: 3940679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Customary diet, anthropometry, and dyslipoproteinemia in selected North American populations. The Lipid Research Clinics Program Prevalence Study.
    Little JA; Graves K; Suchindran CM; Milner J; McGuire V; Beaton G; Feather T; Mattson FH; Christiansen D; Williams OD
    Circulation; 1986 Jan; 73(1 Pt 2):I80-90. PubMed ID: 3940686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group.
    MacLean DR; Petrasovits A; Connelly PW; Joffres M; O'Connor B; Little JA
    Can J Cardiol; 1999 Apr; 15(4):434-44. PubMed ID: 10322253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyslipoproteinemias and manifestations of coronary heart disease. The Lipid Research Clinics Program Prevalence Study.
    Rubenstein C; Romhilt D; Segal P; Heiss G; Chambless LE; Boyle KE; Ekelund LG; Adolph R; Sheffield LT
    Circulation; 1986 Jan; 73(1 Pt 2):I91-9. PubMed ID: 3940687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of dyslipoproteinemia with the use of plasma total cholesterol and triglyceride as screening tests. The Lipid Research Clinics Program Prevalence Study.
    Kwiterovich PO; Stewart P; Probstfield JL; Stinnett S; Chambless LE; Chase GA; Jacobs DR; Morrison JA
    Circulation; 1986 Jan; 73(1 Pt 2):I30-9. PubMed ID: 3940681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of dyslipoproteinemia with corneal arcus and xanthelasma. The Lipid Research Clinics Program Prevalence Study.
    Segal P; Insull W; Chambless LE; Stinnett S; LaRosa JC; Weissfeld L; Halfon S; Kwiterovitch PO; Little JA
    Circulation; 1986 Jan; 73(1 Pt 2):I108-18. PubMed ID: 3940677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Populations and methods for assessing dyslipoproteinemia and its correlates. The Lipid Research Clinics Program Prevalence Study.
    Williams OD; Stinnett S; Chambless LE; Boyle KE; Bachorik PS; Albers JJ; Lippel K
    Circulation; 1986 Jan; 73(1 Pt 2):I4-11. PubMed ID: 3940682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and clustering of nonlipid coronary risk factors in dyslipoproteinemia. The Lipid Research Clinics Program Prevalence Study.
    Criqui MH; Cowan LD; Heiss G; Haskell WL; Laskarzewski PM; Chambless LE
    Circulation; 1986 Jan; 73(1 Pt 2):I40-50. PubMed ID: 3940683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations of plasma high-density lipoprotein cholesterol levels with other plasma lipid and lipoprotein concentrations.
    Davis CE; Gordon D; LaRosa J; Wood PD; Halperin M
    Circulation; 1980 Nov; 62(4 Pt 2):IV24-30. PubMed ID: 7188560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyslipoproteinemia in North America: The Lipid Research Clinics Program Prevalence Study.
    Circulation; 1986 Jan; 73(1 Pt 2):I1-133. PubMed ID: 3940675
    [No Abstract]   [Full Text] [Related]  

  • 12. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of dyslipoproteinemia with symptoms and signs of peripheral arterial disease. The Lipid Research Clinics Program Prevalence Study.
    Pomrehn P; Duncan B; Weissfeld L; Wallace RB; Barnes R; Heiss G; Ekelund LG; Criqui MH; Johnson N; Chambless LE
    Circulation; 1986 Jan; 73(1 Pt 2):I100-7. PubMed ID: 3940676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of female hormone usage on the lipid profile. The Framingham Offspring Study.
    Vaziri SM; Evans JC; Larson MG; Wilson PW
    Arch Intern Med; 1993 Oct; 153(19):2200-6. PubMed ID: 8215723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progeny's lipid and lipoprotein levels by parental mortality. The Lipid Research Clinics Program Prevalence Study.
    Glueck CJ; Laskarzewski PM; Suchindran CM; Chambless LE; Barrett-Connor E; Stewart P; Heiss G; Tyroler HA
    Circulation; 1986 Jan; 73(1 Pt 2):I51-61. PubMed ID: 3940684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyslipoproteinemia in women. Special considerations.
    Miller VT
    Endocrinol Metab Clin North Am; 1990 Jun; 19(2):381-98. PubMed ID: 2192879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma high-density lipoprotein cholesterol and socioeconomic status. The Lipid Research Clinics Program Prevalence Study.
    Heiss G; Haskell W; Mowery R; Criqui MH; Brockway M; Tyroler HA
    Circulation; 1980 Nov; 62(4 Pt 2):IV108-15. PubMed ID: 7418139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in clinical chemistry measures associated with oral contraceptive and estrogen use: the Lipid Research Clinics Program Prevalence Study.
    Cowan LD; Wallace RB; Barrett-Connor E; Hunninghake D; Pomrehn P; Wahl P; Heiss G
    J Reprod Med; 1982 May; 27(5):275-82. PubMed ID: 7108863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
    Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.